First Indoor-Grown Cannabis from Thailand Now Available by Prescription in Australia July 2, 2024 – Brisbane Australia– Alliance Healthcare Australia

is thrilled to announce the launch of two exceptional medical cannabis flower products: 5LEAF NORTH and 5LEAF SOUTH. These premium cannabis strains, the first indoor grown in Thailand, are now available by prescription through authorised prescribers and approved pharmacies across Australia. 

5LEAF NORTH offers a balanced therapeutic blend reported to be ideal for patients managing chronic pain, anxiety, and various other conditions. This hybrid strain combines the uplifting effects of Sativa with the calming properties of Indica, ensuring a comprehensive and effective treatment experience. Meticulously crafted from the cultivar Agent Orange, bred from the genetics of Orange Velvet x Bold Jack the Ripper.  

5LEAF NORTH is a dynamic sativa-dominant hybrid with 22% THC content. Each gram of dried flower contains 22% (w/w) THC (Delta-9-tetrahydrocannabinol) and <1% CBD (Cannabidiol). With a refreshing citrus scent, it’s potentially a great choice and could assist for boosting your mood and alleviating feelings of lethargy or depression. The most abundant terpenes are myrcene and caryophyllene. 

5LEAF SOUTH could be suitable for patients who need strong relief from insomnia, severe pain, and muscle spasms. This hybrid Indica strain provides deep relaxation and comfort, promoting restful sleep and enhanced well-being. Bred from the genetic lineage of Wedding Cake and Cake Crasher, from the Cultivar Cake Krusher. 

5LEAF SOUTH is a robust indica-dominant hybrid cultivar with 25% THC content. Each gram of dried flower contains 25% (w/w) THC (Delta-9-tetrahydrocannabinol) and <1% CBD (Cannabidiol).  

Pioneering Indoor Cultivation in Thailand 

5LEAF NORTH and 5LEAF SOUTH represent the first indoor-grown medical cannabis flower from Thailand, cultivated in a state-of-the-art facility adhering to the highest standards of quality control and sustainability. This ensures each batch is consistent, and free from contaminants, providing reliable and safe options for medical cannabis prescribers and patients. 

Exclusively Through Alliance Healthcare Australia & The Entourage Effect 

These products are available exclusively through Alliance Healthcare Australia (AHA Wholesale & Distribution) & The Entourage Effect. Authorised prescribers and approved pharmacies within this network are educated and equipped to provide tailored therapeutic regimens to meet individual patient needs. 

Commitment to Patient Health and Safety 

Alliance Healthcare Australia is dedicated to advancing the medical cannabis industry by offering safe, effective, and high-quality products. The introduction of 5LEAF NORTH and 5LEAF SOUTH underscores our commitment to enhancing patient outcomes and improving the quality of life for those seeking alternative therapeutic solutions. 

“As a pharmacy-first organisation, we are committed to supporting front-line healthcare professionals. The introduction of 5Leaf is an integral part of our long-term strategy. While broadly available, we aim to provide pharmacies within our network with higher margins, enabling them to deliver quality and compliant patient care. This approach ensures that we remain at the forefront of patient-centric healthcare while supporting the financial sustainability of our network professionals.”  

Rachel Swiatkiewicz, Chief Commercial Officer, Alliance Healthcare Australia. 

About Alliance Healthcare Australia 

Alliance Healthcare Australia is a leading healthcare provider focused on delivering innovative medical solutions and products to improve patient care with the incorporation of natural and traditional medications. Through our extensive network of traditional community pharmacies, we strive to restore margin and support the sustainability of healthcare services across Australia.  

For Pharmacies wanting to incorporate Medicinal Cannabis as a core category and obtain additional margin, visit our website at [www.alliancehealthcareaustralia.com] (http://www.alliancehealthcareaustralia.com). 

Media Contact: 

Rachel Swiatkiewicz 
Chief Commercial Officer 
0466 563 943 
rachel@alliancehealthcare.com.au 
Alliance Healthcare Australia 

Disclaimer: Medical cannabis products should only be used under the guidance of a qualified healthcare professional. Always consult your doctor before starting any new treatment.

For more information about our new products or to schedule an interview, please contact

Rachel Swiatkiewicz at rachel@alliancehealthcare.com.au or 0466 563 943.